Maurizio Cutolo Selected Research

Maurizio Cutolo Research Topics

Disease

100	Rheumatoid Arthritis 01/2022 - 06/2002
38	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 06/2009
23	Inflammation (Inflammations) 02/2022 - 07/2002
21	Rheumatic Diseases (Rheumatism) 02/2022 - 06/2002
17	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2021 - 01/2002
13	Autoimmune Diseases (Autoimmune Disease) 05/2022 - 06/2002
10	Connective Tissue Diseases (Connective Tissue Disease) 05/2022 - 01/2008
10	Arthritis (Polyarthritis) 01/2020 - 02/2005
9	Necrosis 01/2020 - 02/2007
7	Pain (Aches) 10/2018 - 02/2005
6	Disease Progression 10/2020 - 12/2011
6	Osteoarthritis 01/2020 - 12/2003
6	Fibrosis (Cirrhosis) 08/2019 - 10/2010
5	digital ulcers 09/2015 - 01/2010
5	Synovitis 03/2015 - 03/2004
4	Mixed Connective Tissue Disease (MCTD) 01/2022 - 02/2012
4	Undifferentiated Connective Tissue Diseases 01/2022 - 01/2008
4	Raynaud Disease (Raynaud's Disease) 01/2022 - 10/2010
4	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021 - 05/2015
4	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 09/2018 - 04/2002
4	Infections 11/2017 - 12/2008
4	Neoplasms (Cancer) 11/2014 - 06/2002
3	COVID-19 01/2022 - 12/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021 - 01/2021
3	Insulin Resistance 09/2021 - 10/2007
3	Atherosclerosis 09/2021 - 06/2006
3	Vitamin D Deficiency 02/2021 - 01/2008
3	Psoriatic Arthritis 01/2018 - 04/2010
2	Dermatomyositis (Dermatopolymyositis) 11/2021 - 01/2018
2	Muscular Diseases (Myopathy) 05/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 03/2019 - 03/2018
2	Pulmonary Arterial Hypertension 01/2018 - 01/2010
2	Pregnancy Complications 01/2018 - 05/2015
2	Osteoporosis 05/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

29	GlucocorticoidsIBA 01/2022 - 04/2002
21	Estrogens (Estrogen)FDA Link 03/2019 - 06/2002
19	CytokinesIBA 02/2022 - 06/2002
17	Vitamin D FDA LinkGeneric 02/2021 - 05/2007
17	Hormones (Hormone)IBA 07/2019 - 04/2002
14	AndrogensIBA 11/2020 - 06/2002
14	Antirheumatic Agents (DMARD)IBA 02/2020 - 06/2010
14	Biological ProductsIBA 01/2020 - 06/2002
13	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 06/2002
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 07/2005
12	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2014 - 06/2002
11	Biomarkers (Surrogate Marker)IBA 09/2021 - 07/2005
11	SteroidsIBA 11/2020 - 04/2002
10	Abatacept (Orencia)FDA Link 12/2021 - 01/2009
9	AutoantibodiesIBA 02/2022 - 01/2010
9	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017 - 07/2002
9	Prednisone (Sone)FDA LinkGeneric 01/2017 - 01/2009
8	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 05/2009
7	Rituximab (Mabthera)FDA Link 01/2020 - 12/2009
7	Interleukin-6 (Interleukin 6)IBA 09/2018 - 04/2002
6	Adalimumab (Humira)FDA Link 01/2020 - 01/2004
6	Etanercept (Enbrel)FDA Link 01/2020 - 02/2007
6	Infliximab (Remicade)FDA Link 01/2020 - 02/2007
6	tofacitinibIBA 01/2020 - 03/2012
5	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022 - 02/2012
5	Certolizumab Pegol FDA Link 01/2020 - 03/2014
5	Janus Kinase InhibitorsIBA 01/2020 - 03/2012
5	tocilizumab (atlizumab)FDA Link 01/2020 - 04/2013
5	Estrogen ReceptorsIBA 03/2019 - 06/2006
5	Testosterone (Sustanon)FDA Link 03/2019 - 06/2002
4	Monoclonal AntibodiesIBA 12/2021 - 01/2002
4	AntibodiesIBA 01/2020 - 09/2016
4	golimumab FDA Link 01/2020 - 03/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 04/2013
4	Tumor Necrosis Factor InhibitorsIBA 06/2017 - 06/2006
4	ametantrone (HAQ)IBA 05/2017 - 02/2007
4	Bosentan (Tracleer)FDA Link 11/2016 - 05/2014
4	Pharmaceutical PreparationsIBA 05/2016 - 06/2002
4	LipidsIBA 02/2013 - 06/2006
3	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2014
3	Biosimilar PharmaceuticalsIBA 01/2020 - 03/2014
3	Androstenedione (4 Androstene 3,17 dione)IBA 03/2019 - 06/2006
3	Estradiol (Delestrogen)FDA LinkGeneric 03/2019 - 11/2006
3	Antinuclear AntibodiesIBA 01/2019 - 02/2012
3	apremilastIBA 01/2018 - 01/2016
3	25-hydroxyvitamin DIBA 05/2017 - 03/2011
3	hydroxide ionIBA 05/2017 - 05/2014
3	Aromatase (CYP19)IBA 05/2014 - 06/2006
3	MelatoninIBA 05/2008 - 06/2002
3	Dehydroepiandrosterone (DHEA)IBA 03/2004 - 06/2002
2	Endothelins (Endothelin)IBA 05/2021 - 06/2009
2	Antiphospholipid AntibodiesIBA 01/2021 - 01/2018
2	nintedanibIBA 01/2021 - 01/2021
2	sarilumabIBA 01/2020 - 06/2017
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2020 - 10/2014
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 10/2014
2	Janus KinasesIBA 01/2020 - 06/2017
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 06/2017
2	baricitinibIBA 01/2020 - 06/2017
2	InterleukinsIBA 09/2018 - 01/2015
2	Collagen Type I (Type I Collagen)IBA 01/2018 - 01/2017

Therapy/Procedure

29	Therapeutics 01/2022 - 07/2002
11	Lasers (Laser) 01/2022 - 06/2010
4	Chronotherapy 01/2016 - 10/2010
2	Off-Label Use 05/2022 - 03/2011